Vanderbilt researchers discover how anthrax bacterium defends itself against structural damage and resists the toxicity of the antimicrobial drug targocil.

Researchers have developed a method to identify the primary interactions between incoming viral RNA genomes and host proteins.

Howard Price has a decades-old green notebook he keeps in his office at Vanderbilt University Medical Center, and when a shortage of a critical laboratory supply nearly brought testing for SARS-CoV-2, the virus that causes COVID-19, to a halt at the Medical Center, the notebook’s contents quickly became invaluable.

Monoclonal antibodies against Marburg virus — a more lethal cousin of the RNA virus that causes COVID-19 — may aid in the development of antibody “cocktails” to counter viral infection.

A vital ingredient for COVID testing was unavailable anywhere. Then Howard Price remembered a recipe in an old notebook.

The rapid ramping up of SARS-CoV-2 testing at VUMC reflects the dedication of the professionals who work in the Clinical Laboratory and also their collaboration with colleagues in research laboratories throughout VUMC.

Vanderbilt University Medical Center is recruiting volunteers who have tested positive for COVID-19 and fully recovered to donate plasma to help those who are currently ill with the virus as part of a new research study.